Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial

E. Antonio Chiocca*, John S. Yu, Rimas V. Lukas, Isaac H. Solomon, Keith L. Ligon, Hiroshi Nakashima, Daniel A. Triggs, David A. Reardon, Patrick Wen, Brittany M. Stopa, Ajay Naik, Jeremy Rudnick, Jethro L. Hu, Priya Kumthekar, Bakhtiar Yamini, Jill Y. Buck, Nathan Demars, John A. Barrett, Arnold B. Gelb, John ZhouFrancois Lebel, Laurence J.N. Cooper

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

67 Scopus citations

Fingerprint

Dive into the research topics of 'Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences